litlas
Log inCreate account

Frank Buttgereit

Active 1995–2025

Also published as
Frank BUTTGEREIT
128
Papers
32,025
Citations
79
h-index
121
i10-index

Citations

Citations per year for Frank Buttgereit1997: 5 citations1998: 2 citations1999: 7 citations2000: 23 citations2001: 18 citations2002: 28 citations2003: 48 citations2004: 62 citations2005: 64 citations2006: 56 citations2007: 69 citations2008: 110 citations2009: 68 citations2010: 130 citations2011: 137 citations2012: 167 citations2013: 179 citations2014: 261 citations2015: 238 citations2016: 262 citations2017: 306 citations2018: 220 citations2019: 893 citations2020: 1,236 citations2021: 1,227 citations2022: 971 citations2023: 797 citations2024: 1,177 citations2025: 539 citations2026: 24 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,985 citing papers, 16.1% of this breakdownUnited Kingdom: 994 citing papers, 8.1% of this breakdownChina: 945 citing papers, 7.7% of this breakdownGermany: 904 citing papers, 7.3% of this breakdownItaly: 684 citing papers, 5.6% of this breakdownNetherlands: 637 citing papers, 5.2% of this breakdownFrance: 558 citing papers, 4.5% of this breakdownJapan: 455 citing papers, 3.7% of this breakdownCanada: 413 citing papers, 3.3% of this breakdownSpain: 387 citing papers, 3.1% of this breakdownAustralia: 340 citing papers, 2.8% of this breakdownSwitzerland: 293 citing papers, 2.4% of this breakdown
0%16.1%Other 30.2%

Institutions

Fields

  • Medicine67.4%
  • Biochemistry, Genetics and Molecular Biology14.5%
  • Immunology and Microbiology7.2%
  • Neuroscience4.2%
  • Engineering1.8%
  • Dentistry0.8%
  • Other4.1%

Topics

  • Rheumatoid Arthritis Research and Therapies11.3%
  • Systemic Lupus Erythematosus Research3.7%
  • Autoimmune and Inflammatory Disorders Research3.4%
  • Spondyloarthritis Studies and Treatments3.1%
  • Vasculitis and related conditions3%
  • Otitis Media and Relapsing Polychondritis1.5%
  • Other74%

Coauthors

All papers

Open in search
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    Authors: Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher J Edwards, Kimme L Hyrich, Janet Pope, Savia de Souza, Tanja Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin Winthrop, Alejandro Balsa, Joan M. Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Myrna Cardiel, Katerina Chatzidionysiou, Cătălin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques‐Eric Gottenberg, Espen A. Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 cited by 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Authors: Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 5,775

  3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    Authors: Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B. McInnes, Alexandre Sepriano, Ronald van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, Johan Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Myrna Cardiel, Diederik De Cock, Cătălin Codreanu, Maurizio Cutolo, Christopher J Edwards, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques‐Eric Gottenberg, Merete Lund Hetland, T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 cited by 2,766

  4. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis

    Authors: Bernhard Hellmich, Ana Águeda, Sara Monti, Frank Buttgereit, Hubert de Boysson, Elisabeth Brouwer, Rebecca Cassie, María C. Cid, Bhaskar Dasgupta, Christian Dejaco, Gülen Hatemi, Nicole Hollinger, Alfred Mahr, Susan P. Mollan, Chetan Mukhtyar, Cristina Ponte, Carlo Salvarani, Rajappa Sivakumar, Xinping Tian, Gunnar Tómasson, Carl Turesson, Wolfgang Schmidt, Peter M. Villiger, Richard A. Watts, Chris Young, Raashid Luqmani - Annals of the Rheumatic Diseases 2019 cited by 1,170

  5. Metabolic regulation of inflammation

    Authors: Timo Gaber, Cindy Strehl, Frank Buttgereit - Nature Reviews Rheumatology 2017 cited by 326

  6. A hierarchy of ATP-consuming processes in mammalian cells

    Authors: Frank Buttgereit, Martin D. Brand - Biochemical Journal 1995 cited by 929

  7. Dose-related patterns of glucocorticoid-induced side effects

    Authors: Dörte Huscher, K. Thiele, Erika Gromnica‐Ihle, Gert Hein, W. Demary, R. Dreher, A. Zink, Frank Buttgereit - Annals of the Rheumatic Diseases 2008 cited by 582

  8. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

    Authors: Christian Dejaco, Christina Duftner, Frank Buttgereit, Eric L. Matteson, Bhaskar Dasgupta - Lara D. Veeken 2016 cited by 364

  9. Recruitment and Retention of Older People in Clinical Research: A Systematic Literature Review

    Authors: Noah D. Forsat, Andriko Palmowski, Yannick Palmowski, Maarten Boers, Frank Buttgereit - Journal of the American Geriatrics Society 2020 cited by 212

  10. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

    Authors: Christian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, Milena Bond, Elvis Hysa, Dario Camellino, Lisa Ehlers, Andy Abril, Simone Appenzeller, María C. Cid, Bhaskar Dasgupta, Christina Duftner, Peter C. Grayson, Bernhard Hellmich, Alojzija Hočevar, Tanaz A. Kermani, Eric L. Matteson, Susan P. Mollan, Lorna Neill, Cristina Ponte, Carlo Salvarani, Sebastian E. Sattui, Wolfgang Schmidt, Philip Seo, Josef S Smolen, Jens Thiel, Carlos Enrique Toro Gutiérrez, Madeline Whitlock, Frank Buttgereit - Annals of the Rheumatic Diseases 2023 cited by 114

  11. Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

    Authors: Maarten Boers, Linda Hartman, Daniela Opriș-Belinski, Reinhard Bos, Marc R. Kok, José António Pereira da Silva, Eduard N. Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G. Raterman, Zoltán Szekanecz, Frank Buttgereit, P. Masaryk, L Thomas Klausch, Sabrina Paolino, A. Schilder, Willem F. Lems, Maurizio Cutolo, LM Middelink, V Dekker, N van den Bulk, RMA Pinto, L Doerwald, S Manger, J Redol, K Prinsen, M Scholte-Voshaar, TLTA Jansen, C Codreanu, E Molenaar, JM van Laar, YPM Ruiterman, AERCH Boonen, AERCH Boonen, M Micaelo, J Costa, M Sieburg, JPL Spoorenberg, U Prothmann, MJ Saavedra, I Silva, MT Nurmohamed, JWG Jacobs, SW Tas, JWJ Bijlsma, R Christensen, YM Smulders, SH Ralston, DMFM van der Heijde, AF Marsman, WF Lems, C Rusthoven, M Bakkers, E Frazão Mateus, G Mendes, C Elling-Audersch, D Borucki, A Celano, P Corduta, O Constantinescu, P Richards, GJ Aanerud - Annals of the Rheumatic Diseases 2022 cited by 161

  12. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis

    Authors: Eli M. Miloslavsky, Ray Naden, J. W. J. Bijlsma, Paul Brogan, E. Sherwood Brown, Paul Brunetta, Frank Buttgereit, Hyon K. Choi, Jean-Francois Dicaire, Jeffrey M. Gelfand, Liam G. Heaney, Liz Lightstone, Na Lu, Dédée F. Murrell, Michelle Petri, James T. Rosenbaum, Kenneth S. Saag, Murray B. Urowitz, Kevin Winthrop, John H. Stone - Annals of the Rheumatic Diseases 2016 cited by 231

  13. Polymyalgia Rheumatica and Giant Cell Arteritis

    Authors: Frank Buttgereit, Christian Dejaco, Eric L. Matteson, Bhaskar Dasgupta - JAMA 2016 cited by 488

  14. European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations

    Authors: Matthias Löhr, Ulrich Beuers, Miroslav Vujasinović, Domenico Alvaro, Jens Brøndum Frøkjær, Frank Buttgereit, Gabriele Capurso, Emma Culver, Enrique de‐Madaria, Emanuel Della‐Torre, Sönke Detlefsen, J. Enrique Domínguez‐Muñoz, Piotr Czubkowski, Nils Ewald, Luca Frulloni, N. B. Gubergrits, Deniz Duman, Thilo Hackert, Julio Iglesias‐García, Nikolaos Kartalis, Andrea Laghi, Frank Lammert, Fredrik Lindgren, А. В. Охлобыстин, Grzegorz Oracz, Andrea Párniczky, Raffaella Pozzi Mucelli, Vinciane Rebours, Jonas Rosendahl, N. Schleinitz, Alexander Schneider, Eric F.H. van Bommel, Caroline S. Verbeke, Marie‐Pierre Vullierme, Heiko Witt, the UEG guideline working group - United European Gastroenterology Journal 2020 cited by 238

  15. Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind, Active‐Controlled Proof‐of‐Concept Phase IIa Trial

    Authors: Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, Anna Zubrzycka‐Sienkiewicz, Su Chen, Yang� Yang, Dilek Arikan, Ronilda D’Cunha, Yinuo Pang, H. Küpper, Timothy R. D. J. Radstake, Howard Amital - Arthritis & Rheumatology 2022 cited by 53

  16. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

    Authors: Robert Spiera, Sebastian Unizony, Kenneth J. Warrington, Jennifer Sloane, Angeliki Giannelou, Michael C. Nivens, Bolanle Akinlade, Wanling Wong, Rafia Bhore, Yong Lin, Frank Buttgereit, Valérie Devauchelle‐Pensec, Andrea Rubbert‐Roth, George D. Yancopoulos, Frédéric Marrache, Naimish Patel, Bhaskar Dasgupta - New England Journal of Medicine 2023 cited by 113

  17. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

    Authors: Frank Buttgereit, J A P Da Silva, M Boers, G-R Burmester, M Cutolo, J Jacobs, J Kirwan, L Köhler, P van Riel, T Vischer, J W J Bijlsma - Annals of the Rheumatic Diseases 2002 cited by 548

  18. Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System

    Authors: Cindy Strehl, Lisa Ehlers, Timo Gaber, Frank Buttgereit - Frontiers in Immunology 2019 cited by 292

  19. Quantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing

    Authors: Michael F. Princiotta, Diana Finzi, Shu‐Bing Qian, James S. Gibbs, Sebastian Schuchmann, Frank Buttgereit, Jack R. Bennink, Jonathan W. Yewdell - Immunity 2003 cited by 523

  20. Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases

    Authors: Rainer H. Straub, Maurizio Cutolo, Frank Buttgereit, Georg Pongratz - Journal of Internal Medicine 2010 cited by 383

  21. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

    Authors: Cindy Strehl, J. W. J. Bijlsma, Maarten de Wit, Maarten Boers, N. Caeyers, Maurizio Cutolo, Bhaskar Dasgupta, William G Dixon, Rinie Geenen, T. Huizinga, Alison Kent, Annette de Thurah, Joachim Listing, Xavier Mariette, David Ray, Hans Ulrich Scherer, Raphaèle Séror, Cornelia M Spies, Simon Tarp, Dieter Wiek, Kevin Winthrop, Frank Buttgereit - Annals of the Rheumatic Diseases 2016 cited by 331

  22. Inflammatory phase of bone healing initiates the regenerative healing cascade

    Authors: Katharina Schmidt‐Bleek, Hanna Schell, Norma Schulz, Paula Hoff, Carsten Perka, Frank Buttgereit, Hans‐Dieter Volk, Jasmin Lienau, Georg N. Duda - Cell and Tissue Research 2011 cited by 278

  23. Views on glucocorticoid therapy in rheumatology: the age of convergence

    Authors: Frank Buttgereit - Nature Reviews Rheumatology 2020 cited by 116

  24. Spatial Distribution of Macrophages During Callus Formation and Maturation Reveals Close Crosstalk Between Macrophages and Newly Forming Vessels

    Authors: Jonathan Stefanowski, Annemarie Lang, Ariana Rauch, Linus Aulich, Markus Köhler, Alexander F. Fiedler, Frank Buttgereit, Katharina Schmidt‐Bleek, Georg N. Duda, Timo Gaber, Raluca Niesner, Anja E. Hauser - Frontiers in Immunology 2019 cited by 72